Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset

被引:6
作者
Espinos-Gomez, Juan J. [1 ]
Rodriguez-Espinosa, J. [2 ]
Ordonez-Llanos, J. [2 ]
Calaf-Alsina, J. [1 ]
机构
[1] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Obstet & Gynecol, E-08025 Barcelona, Spain
[2] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Biochem, E-08025 Barcelona, Spain
关键词
Metabolic syndrome; polycystic ovary syndrome; cardiovascular risk; INSULIN SENSITIVITY; PREVALENCE; OBESITY; CRITERIA; GLUCOSE; RISK;
D O I
10.3109/09513590.2011.613968
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Polycystic ovary syndrome (PCOS) is associated with the metabolic syndrome (MetS). The metabolic disorders are not universal and may vary with race, age and phenotype. Our purpose was to determine the clinical and biochemical characteristics of Mediterranean PCOS women with MetS, compare them with non-MetS PCOS patients, and assess the ability of clinical data and biochemical tests to predict these abnormalities within our population. A total of 218 subjects, 196 PCOS women and 22 controls, undergo a physical examination and laboratory evaluation for a diagnosis of MetS. MetS was categorized according to NCEP ATP III guidelines. PCOS patients were analyzed separately and compared in three subgroups: three or more MetS criteria, two criteria, one or no criteria. The overall prevalence of MetS was 21.4%. Women with MetS had higher glucose (G) levels than PCOS women with two criteria (5.7 +/- 1.5 vs 5 +/- 0.4, p < 0.05). Both groups were comparable for all the other parameters. Waist circumference (WC), body mass index (BMI), systolic (SBP) and diastolic blood pressure (DBP), bioavailable testosterone (uT), triglycerides (TG) and insulin (I) levels were significantly higher and sex hormone-binding globulin (SHBG) levels, high-density lipoprotein (HDL), HOMA and QUICKI indexes significantly lower in both groups, MetS and patients with two criteria, compared with women with one or no criteria and the control group. WC, HDL and TG were the best predictors of PCOS patients at risk for MetS. In conclusion, we recommend considering PCOS patients with two criteria of MetS as having the same risk as patients with the full syndrome. Waist circumference with HDL and triglycerides is an efficient combined test to identify PCOS women at risk for metabolic and cardiovascular diseases.
引用
收藏
页码:264 / 268
页数:5
相关论文
共 30 条
  • [1] Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome
    Apridonidze, T
    Essah, PA
    Iuorno, MJ
    Nestler, JE
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04) : 1929 - 1935
  • [2] The prevalence and features of the polycystic ovary syndrome in an unselected population
    Azziz, R
    Woods, KS
    Reyna, R
    Key, TJ
    Knochenhauer, ES
    Yildiz, BO
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) : 2745 - 2749
  • [3] Obesity and polycystic ovary syndrome
    Barber, T. M.
    McCarthy, M. I.
    Wass, J. A. H.
    Franks, S.
    [J]. CLINICAL ENDOCRINOLOGY, 2006, 65 (02) : 137 - 145
  • [4] Selective insulin resistance in the polycystic ovary syndrome
    Book, CB
    Dunaif, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (09) : 3110 - 3116
  • [5] Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS
    Carmina, E
    Napoli, N
    Longo, RA
    Rini, GB
    Lobo, RA
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2006, 154 (01) : 141 - 145
  • [6] Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance
    Carmina, Enrico
    Bucchieri, Salvo
    Esposito, Antonella
    Del Puente, Antonio
    Mansueto, Pasquale
    Orio, Francesco
    Di Fede, Gaetana
    Rini, GiovamBattista
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (07) : 2500 - 2505
  • [7] Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
    Chang, J
    Azziz, R
    Legro, R
    Dewailly, D
    Franks, S
    Tarlatzis, BC
    Fauser, B
    Balen, A
    Bouchard, P
    Dahlgren, E
    Devoto, L
    Diamanti, E
    Dunaif, A
    Filicori, M
    Homburg, R
    Ibanez, L
    Laven, J
    Magoffin, D
    Nestler, J
    Norman, RJ
    Pasquali, R
    Pugeat, M
    Strauss, J
    Tan, S
    Taylor, A
    Wild, R
    Wild, S
    Ehrmann, D
    Lobo, R
    [J]. FERTILITY AND STERILITY, 2004, 81 (01) : 19 - 25
  • [8] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [9] Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance
    Coviello, AD
    Legro, RS
    Dunaif, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (02) : 492 - 497
  • [10] Screening women with polycystic ovary syndrome for metabolic syndrome
    Dokras, A
    Bochner, M
    Hollinrake, E
    Markham, S
    VanVoorhis, B
    Jagasia, DH
    [J]. OBSTETRICS AND GYNECOLOGY, 2005, 106 (01) : 131 - 137